This bill represents an important step toward increasing transparency and accountability in prescription drug pricing, which directly impacts the affordability of health care for Virginians.  By requiring health carriers, pharmacy benefit managers, drug manufacturers, and wholesale distributors to report comprehensive cost data, the legislation ensures that policymakers, providers, and the public have access to accurate information about how drug prices are determined.  Partnering with a nonprofit data services organization to compile and publish this information further strengthens public trust, providing an objective and accessible source of data.  The inclusion of civil penalties for noncompliance emphasizes the seriousness of the reporting requirements and helps guarantee the integrity of the process.  Ultimately, this bill empowers the state to identify cost drivers in the pharmaceutical supply chain and pursue meaningful reforms that protect patients from rising drug costs.